MEREO BIOPHARMA GROUP PLC Stock Issued During Period, Shares, New Issues
MEREO BIOPHARMA GROUP PLC (MREO) reported Stock Issued During Period, Shares, New Issues of 1.55 million shares for the 1-month period ending 2026-02-28, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2026-08-11
- 2026-02-28: Stock Issued During Period, Shares, New Issues 1 month 1.55M shares.
- 2025-02-28: Stock Issued During Period, Shares, New Issues 1 month 17.11M shares.
- 2024-06-30: Stock Issued During Period, Shares, New Issues 1 month 12.53M shares.
- 2024-06-17: Stock Issued During Period, Shares, New Issues 12.53M shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|---|
| 2026-02-28 | 1.55M shares 10-Q · filed 2026-08-11 | |
| 2025-02-28 | 17.11M shares 10-K · filed 2026-03-19 | |
| 2024-06-30 | 12.53M shares 10-K · filed 2025-03-26 | |
| 2024-06-17 | 12.53M shares 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |